Kyle B. Kener
Brigham Young University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kyle B. Kener.
American Journal of Physiology-endocrinology and Metabolism | 2016
Merrick Reynolds; Chad R. Hancock; Jason D. Ray; Kyle B. Kener; Carrie Draney; Kevin Garland; Jeremy M. Hardman; Benjamin T. Bikman; Jeffery S. Tessem
β-Cell insulin secretion is dependent on proper mitochondrial function. Various studies have clearly shown that the Nr4a family of orphan nuclear receptors is essential for fuel utilization and mitochondrial function in liver, muscle, and adipose. Previously, we have demonstrated that overexpression of Nr4a1 or Nr4a3 is sufficient to induce proliferation of pancreatic β-cells. In this study, we examined whether Nr4a expression impacts pancreatic β-cell mitochondrial function. Here, we show that β-cell mitochondrial respiration is dependent on the nuclear receptors Nr4a1 and Nr4a3. Mitochondrial respiration in permeabilized cells was significantly decreased in β-cells lacking Nr4a1 or Nr4a3. Furthermore, respiration rates of intact cells deficient for Nr4a1 or Nr4a3 in the presence of 16 mM glucose resulted in decreased glucose mediated oxygen consumption. Consistent with this reduction in respiration, a significant decrease in glucose-stimulated insulin secretion rates is observed with deletion of Nr4a1 or Nr4a3. Interestingly, the changes in respiration and insulin secretion occur without a reduction in mitochondrial content, suggesting decreased mitochondrial function. We establish that knockdown of Nr4a1 and Nr4a3 results in decreased expression of the mitochondrial dehydrogenase subunits Idh3g and Sdhb. We demonstrate that loss of Nr4a1 and Nr4a3 impedes production of ATP and ultimately inhibits glucose-stimulated insulin secretion. These data demonstrate for the first time that the orphan nuclear receptors Nr4a1 and Nr4a3 are critical for β-cell mitochondrial function and insulin secretion.
FEBS Letters | 2016
Jason D. Ray; Kyle B. Kener; Benjamin F. Bitner; Brent Wright; Matthew S. Ballard; Emily Barrett; Jonathon T. Hill; Larry G. Moss; Jeffery S. Tessem
Understanding the molecular pathways that enhance β‐cell proliferation, survival, and insulin secretion may be useful to improve treatments for diabetes. Nkx6.1 induces proliferation through the Nr4a nuclear receptors, and improves insulin secretion and survival through the peptide hormone VGF. Here we demonstrate that Nkx6.1‐mediated upregulation of Nr4a1, Nr4a3, and VGF is dependent on c‐Fos expression. c‐Fos overexpression results in activation of Nkx6.1 responsive genes and increases β‐cell proliferation, insulin secretion, and cellular survival. c‐Fos knockdown impedes Nkx6.1‐mediated β‐cell proliferation and insulin secretion. These data demonstrate that c‐Fos is critical for Nkx6.1‐mediated expansion of functional β‐cell mass.
Journal of Visualized Experiments | 2018
Kyle B. Kener; Devin J. Munk; Chad R. Hancock; Jeffery S. Tessem
High-resolution respirometry allows for the measurement of oxygen consumption of isolated mitochondria, cells and tissues. Beta cells play a critical role in the body by controlling blood glucose levels through insulin secretion in response to elevated glucose concentrations. Insulin secretion is controlled by glucose metabolism and mitochondrial respiration. Therefore, measuring intact beta cell respiration is essential to be able to improve beta cell function as a treatment for diabetes. Using intact 832/13 INS-1 derived beta cells we can measure the effect of increasing glucose concentration on cellular respiration. This protocol allows us to measure beta cell respiration in the presence or absence of various compounds, allowing one to determine the effect of given compounds on intact cell respiration. Here we demonstrate the effect of two naturally occurring compounds, monomeric epicatechin and curcumin, on beta cell respiration under the presence of low (2.5 mM) or high glucose (16.7 mM) conditions. This technique can be used to determine the effect of various compounds on intact beta cell respiration in the presence of differing glucose concentrations.
Journal of Nutritional Biochemistry | 2018
Benjamin F. Bitner; Jason D. Ray; Kyle B. Kener; Jacob A. Herring; Josie A. Tueller; Deborah K. Johnson; Claudia M. Tellez Freitas; Dane W. Fausnacht; Mitchell E. Allen; Alexander H. Thomson; K. Scott Weber; Ryan P. McMillan; Matthew W. Hulver; David A. Brown; Jeffery S. Tessem; Andrew P. Neilson
Flavonoids are dietary compounds with potential anti-diabetes activities. Many flavonoids have poor bioavailability and thus low circulating concentrations. Unabsorbed flavonoids are metabolized by the gut microbiota to smaller metabolites, which are more bioavailable than their precursors. The activities of these metabolites may be partly responsible for associations between flavonoids and health. However, these activities remain poorly understood. We investigated bioactivities of flavonoid microbial metabolites [hippuric acid (HA), homovanillic acid (HVA), and 5-phenylvaleric acid (5PVA)] in primary skeletal muscle and β-cells compared to a native flavonoid [(-)-epicatechin, EC]. In muscle, EC was the most potent stimulator of glucose oxidation, while 5PVA and HA simulated glucose metabolism at 25 μM, and all compounds preserved mitochondrial function after insult. However, EC and the metabolites did not uncouple mitochonndrial respiration, with the exception of 5PVA at10 μM. In β-cells, all metabolites more potently enhanced glucose-stimulated insulin secretion (GSIS) compared to EC. Unlike EC, the metabolites appear to enhance GSIS without enhancing β-cell mitochondrial respiration or increasing expression of mitochondrial electron transport chain components, and with varying effects on β-cell insulin content. The present results demonstrate the activities of flavonoid microbial metabolites for preservation of β-cell function and glucose utilization. Additionally, our data suggest that metabolites and native compounds may act by distinct mechanisms, suggesting complementary and synergistic activities in vivo which warrant further investigation. This raises the intriguing prospect that bioavailability of native dietary flavonoids may not be as critical of a limiting factor to bioactivity as previously thought.
Diabetes | 2018
Courtney Smith; Kyle B. Kener; Jeffery S. Tessem
Biochemical Journal | 2018
Carrie Draney; Matthew C. Austin; Aaron H. Leifer; Courtney Smith; Kyle B. Kener; Talon J. Aitken; Kavan H. Hess; Amanda C. Haines; Lanair A. Lett; Angelina Hernandez-Carretero; Patrick T. Fueger; Michelle Arlotto; Jeffery S. Tessem
Journal of Insulin Resistance | 2017
MaryJane Sampson; Daniel R. Lathen; Blake W. Dallon; Carrie Draney; Jason D. Ray; Kyle B. Kener; Brian A. Parker; Jonathan L. Gibbs; Jarom S. Gropp; Jeffery S. Tessem; Benjamin T. Bikman
UCUR 2017 | 2016
Kyle B. Kener
UCUR 2016 | 2015
Kyle B. Kener; Jeffery S. Tessem
UCUR 2016 | 2015
Jason D. Ray; Kyle B. Kener; Ben Bitner; Brent Wright; Matthew S. Ballard; Justin Bosley; Larry G. Moss